- ►diabetesjournals.org E Rask, T Olsson, S Söderberg, O Johnson, J … - Diabetes Care, 2001 - Am Diabetes Assoc RESULTS—Insulin resistance was associated with impaired GIP and GLP-1
responses to a mixed meal. The total area under the curve (AUC) of the GIP
response after the mixed meal was associated with insulin sensitivity (r = ... Cited by 45 - Related articles - BL Direct - All 6 versions
M Bryer-Ash, A Cheung, RA Pederson - Regulatory peptides, 1994 - Elsevier Feedback regulation of glucose-dependent insulinotropic polypeptide (GIP) was
studied in a conscious rat model. Male Wistar rats were preconditioned to
partial restraint, the tail artery and vein were cannulated under local ... Cited by 14 - Related articles - All 4 versions
E Mannucci, A Ognibene, F Cremasco, G … - Diabetic medicine, 2000 - ingentaconnect.com Aims To assess differences in circulating leptin and glucagon-like peptide
(GLP)-1 concentrations before and after an oral glucose load, in euglycaemic and
isoinsulinaemic conditions, between obese patients with and without Type 2 ... Cited by 33 - Related articles - BL Direct - All 6 versions
KR Sirinek, WG Pace, SE Crockett, TM O' … - American journal of surgery, 1978 - ncbi.nlm.nih.gov Administration of exogenous insulin before and after intraduodenal glucose
results in blunting of the GIP response to glucose. Physiologic levels of serum
insulin were attained. Therefore, the present study suggests the existence ... Cited by 11 - Related articles
PL Brubaker, S Efendic, GR Greenberg - Endocrine, 1997 - Springer Page 1. Endocrine, vol. 6, no. 1, 91-95, February 1997 0969-71 lX/97/6:91-95/$9.25
9 1997 by Humana Press Inc. All rights of any nature whatsoever reserved. ... Cited by 13 - Related articles - BL Direct - All 2 versions
- ►endojournals.org Y Anini, T Hansotia, PL Brubaker - Endocrinology, 2002 - Endocrine Soc THE INSULINOTROPIC hormone glucagon-like peptide-1 [GLP-1-(7–36) amide] is
secreted by enteroendocrine L cells in the distal intestine and colon in
response to nutrient ingestion, especially fat and carbohydrates (1, 2). ... Cited by 57 - Related articles - BL Direct - All 4 versions
T Vilsbøll, T Krarup, S Madsbad, J Holst - Diabetologia, 2002 - Springer Aims/hypothesis. Glucagon-like-peptide-1 (GLP-1) is strongly insulinotropic in
patients with Type II (non- insulin-dependent) diabetes mellitus, whereas glu-
cose-dependent insulinotropic polypeptide (GIP) is less effective. Our ... Cited by 135 - Related articles - BL Direct - All 4 versions
- ►endojournals.org Y Anini, PL Brubaker - Endocrinology, 2003 - Endocrine Soc Glucagon-like peptide 1 (GLP-1) released from distal intestinal endocrine L
cells after food intake is a potent glucose-dependent stimulant of insulin
secretion. Plasma levels of GLP-1 rise rapidly after nutrient ingestion ... Cited by 44 - Related articles - BL Direct - All 4 versions
R Lugari, A Dei Cas, D Ugolotti, L Finardi, … - Horm Metab Res, 2002 - thieme-connect.com Results: In the control group, the test meal induced a significant increase in
plasma GLP-1 at 30′ and 60′ (p < 0.01); the peptide concentrations then
returning toward basal levels. ?-cell function estimation by HOMA score ... Cited by 48 - Related articles - All 4 versions
- ►shouxi.net Y Anini, PL Brubaker - Diabetes, 2003 - Am Diabetes Assoc Glucagon-like peptide-1 (GLP-1), released from intestinal endocrine L cells, is
a potent insulinotropic hormone. GLP-1 secretion is diminished in obese
patients. Because obesity is linked to abnormal leptin signaling, we ... Cited by 65 - Related articles - BL Direct - All 7 versions
